Over the last 20 years the WMFC members have generously supported a tremendous amount of research. Some of it has been groundbreaking, helping change the lives of Canadian WMers for the better. As an organization, the WMFC is now focusing on raising funds for research for one month each year. July is research month this year. The resulting development of new treatments has been a benefit to every WMer in Canada.
The four research projects we are currently supporting are:
Below is a chart of the WMFC’s investment in research to date. Research has made such a difference. WM is now better controlled through advanced treatment and, secondly, in allowing us to work toward that elusive cure.
We are asking you to consider making a donation to support this research. Not every WMer in Canada has the means to make a financial contribution. If you are not able to support us financially, we fully understand, especially during the COVID-19 pandemic. In this case, please send us a note and let us know that we have your support. For those who can, we appreciate your contribution.
You can make a donation online by going to our website www.wmfc.ca and clicking on the Donate button. We are counting on Canadian WMers to come through again.
WMFC Board Chair
WMFC’s Investment in Research to Date
|Years||Total CD $||Research Institute||Lead Investigators||Research being undertaken|
|2005-07||$100,000||Alberta Cancer Board
|Pilarski||1. Genetic Characteristics of WM|
|2009-11||$99,935||BC Cancer Agency
|Nelson||2. The Immune Response to WM|
|Carrasco||3. WM Mouse Model|
|2014-16||$163,970||BC Cancer Agency
|4. Adoptive T cell therapy for WM.|
|Carrasco||5. Continuation of 2012-15 research|
|Treon||6. Epigenomic Roadmap of WM|
|2019-20||$96,421||University Health Network
|Chen and Trudel||7. Peripheral blood in diagnosis of WM|
|Hunter||8. Multiomic Analysis of DNA, RNA, and Epigenomic Networks for Prognostication and Novel Target Identification in WM|